Key result
Higher plasma levels of galectin-4 were associated with an increased risk of coronary heart disease, a finding that was successfully replicated in an independent cohort.
Why the study?
Atherosclerosis is the main cause of stroke and coronary heart disease, and high-throughput proteomics could provide insights into its underlying pathological mechanisms.
Are specific plasma proteins associated with coronary heart disease and carotid intima-media thickness in a population-based cohort?
Cohort (n=999)
No
Are specific plasma proteins associated with coronary heart disease and carotid intima-media thickness in a population-based cohort?
Answers are grounded in this paper and cite their sources.
Background and aims: Atherosclerosis is the main cause of stroke and coronary heart disease (CHD), both leading mortality causes worldwide. Proteomics, as a high-throughput method, could provide helpful insights into the pathological mechanisms underlying atherosclerosis. In this study, we characterized the associations of plasma protein levels with CHD and with carotid intima-media thickness (CIMT), as a surrogate measure of atherosclerosis. Methods: The discovery phase included 1000 participants from the KORA F4 study, whose plasma protein levels were quantified using the aptamer-based SOMAscan proteomics platform. We evaluated the associations of plasma protein levels with CHD using logistic regression, and with CIMT using linear regression. For both outcomes we applied two models: an age-sex adjusted model, and a model additionally adjusted for body mass index, smoking status, physical activity, diabetes status, hypertension status, low density lipoprotein, high density lipoprotein, and triglyceride levels (fully-adjusted model). The replication phase included a matched case-control sample from the independent KORA F3 study, using ELISA-based measurements of galectin-4. Pathway analysis was performed with nominally associated proteins (p-value < 0.05) from the fully-adjusted model. Results: In the KORA F4 sample, after Bonferroni correction, we found CHD to be associated with five proteins using the age-sex adjusted model: galectin-4 (LGALS4), renin (REN), cathepsin H (CTSH), and coagulation factors X and Xa (F10). The fully-adjusted model yielded only the positive association of galectin-4 (OR = 1.58, 95% CI = 1.3 - 1.93), which was successfully replicated in the KORA F3 sample (OR = 1.40, 95% CI = 1.09 - 1.88). For CIMT, we found four proteins to be associated using the age-sex adjusted model namely: cytoplasmic protein NCK1 (NCK1), insulin-like growth factor-binding protein 2 (IGFBP2), growth hormone receptor (GHR), and GDNF family receptor alpha-1 (GFRA1). After assessing the fully-adjusted model, only NCK1 remained significant (ꞵ = 0.017, p-value = 1.39e-06). Upstream regulators of galectin-4 and NCK1 identified from pathway analysis were predicted to be involved in inflammation pathways. Conclusions: Our proteome-wide association study identified galectin-4 to be associated with CHD and NCK1 to be associated with CIMT. Inflammatory pathways underlying the identified associations highlight the importance of inflammation in the development and progression of CHD.
No takes yet. Share an insight, caveat, or question.
Elhadad et al. (2023) conducted a cohort in Coronary Heart Disease and Atherosclerosis (n=999). Plasma galectin-4 levels vs. Per 1 standard deviation increase in log2-transformed protein levels was evaluated on Association with Coronary Heart Disease (CHD) in the fully-adjusted model (OR 1.58, 95% CI 1.30-1.93, p=5.50E-06). Higher plasma levels of galectin-4 were associated with an increased risk of coronary heart disease, a finding that was successfully replicated in an independent cohort.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: